Caralluma 960

Table of contents research: sources sources and source composition Neurology appetite interactions interactions with the glucose metabolism of the interactions with the metabolism of lipids and lipoproteins triglycerides safety and toxicity of 1 sources1. 1. sources and OriginCaralluma is a very growing plant in the India and is associated with the Suppression of the appetite. [1] most important, grass added for appetite suppression Caralluma Adscendens var, Fimbriata and often called Caralluma Fimbriata, contains a large number of both specific molecules only. [2] the genus Caralluma is Oleander (Apocynaceae) and the family Apocynaceae (divided into three subgenera, Boucerosia, Desmidorchis and Urmalcala; [(Die Familie verwendet, um als Asclepiadaceae zusammengeführt werden bezeichnet werden Apocynaceae), with over 260 species, the name of the genus Caralluma is distributed throughout Asia and in the Mediterranean region [4] and in General linked to a variety of traditional old z.] B. treatment of rheumatism, diabetes, leprosy, paralysis and inflammation also have malaria] Meanwhile, anti-ulcer, antioxidant, effect and proliferative Antinociceptive activity antileishmania. [4] visual Caralluma plants are perennial, succulent square small deciduous and are sometimes used to power. [4] 1-2 CompositionAs a herbal compound, Caralluma (genus in General) contains a variety of bioactive compounds comprising: glycosides of pregnane [5] [6] [2] [7], including Russeliosides B and C, V caralluma 960 Stalagmoside and Caraumbellogenin class; Glycosides are based on the skeleton of Calogerin, 5alpha-Dihydrocalogerin and Boucerin ridges [7] as the Suppression of appetite [1] reached the sum of Caraumbelloside-III and Boucerin up to 4% of the plant finds, discovered without antenna Megastigmane glycosides GlycosidesLuteolin [8] [9] of flavonoids and their glycosides [9] the Pentatriacontane of hydrocarbons [4] chromium [4] part suspected SitosterolTheingredienti beta-bioactives are pregnane glycosides (because of the appetite suppressing herb Hoodia with) pregnane glycosides as main part) but exact Glycoside that causes most of the effects is not known. Pregane most share similar structures of glycosides of Caralluma. 2 interactions with Neurology2. 1 AppetiteOne human intervention (n = 62 50 first endings) taking Caralluma in obese people has pointed out, that 1 g (made by aqueous plant, 40/60/ethanol; extract 12: 1 extract concentrate equivalent to 12 g air drying system) could lead to 2. 5% loss of weight within 60 days, what induced placebo 1. 2% weight loss, if the two groups were subjected to loss of standard weight through calorie restriction. [1] only life is decreased significantly, while the weight and body fat has a tendency to value with the values of P 15-0 and 0. 07, or [1] final fat loss was 1 2 0 kg 2 kg in the placebo Caralluma group and the effects were hypothetically to fame (important) and the desire to eat reduced (non-significant) influence saturation (feeling of fullness) and Caralluma showed a deficit of 200 kcal during placebo does not indicate that these effects of loss of fat from the adherence to the diet were secondary. [1] this study found the 20% reduction in hunger subjective, which was responsible for a reduction of 8% in the diet. [1]These effects were in a study with rats administered Caralluma Fimbriata, 25, 50 and 100 mg/kg p. c., for 90 days in connection with a scheme of lib (no food control) in a dose-dependent reduction in food intake and body weight caused were imitated, balanced with the regime of control diet Caralluma Fed group limited obesogenic (both obesogenic Caralluma diet eat more control). [10] the impact of this study seem to occur after 45 days, which suggests that the use of non-acute (human study was not to answer the question, response time). [10]Mechanically, it is known as Caralluma suppresses appetite. The previous hypothesis, can be through pregnane glycosides and act similarly to the glycosides steroidal of Hoodia to increase hypothalamic ATP to reduce appetite. [11] according to preliminary appetite of Caralluma Fimbriata, can suppress similar mechanisms such as Hoodia. Effects require continuous supplements (and therefore possibly the effects of placebo for acute supplementation) if the study in rats to humans is applicable, but not quite sure3 tests. Interactions with the intervention of the blood glucose MetabolismAn measure glucose fasting and postprandial (after meal) was observed significant differences between placebo and 1 g Caralluma during a period of 60 days. [1] 4 interactions with the lipid Metabolism4. 1 note of triglycerides and intervention human LipoproteinsOne with 1 g of Caralluma does not change with total cholesterol, LDL, HDL, and triglycerides in a period of 60 days. [1], the study 25,50 and 100 mg/kg underscored by 90 days a period of rat that Caralluma Plus abnormal lipid profiles obesogenic diet and leptin levels induced by abnormal diet, with better standardization within the Group of standardized 100 mg/kg, measured in 90 days and which represents a reduction of food intake, less Artherogenic plate was created earlier. [10] 5 safety animal ToxicityAn and unpublished experimental study on evaluation of Caralluma LD50 (see the discussion here [1], Kurpad et al.) observed a significant toxicity associated with Caralluma of 5 g/kg / day. Only human study on this topic with 1 g Caralluma daily I have not noticed any side effects is very different from placebo. [1]. . . . .